Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

John Graham, PharmD

Advertisement

Articles by John Graham, PharmD

Graham and Ross

Anchoring HEOR Evidence Generation in the Challenge from the Market

ByJohn Graham, PharmD,Ross Maclean, MD
March 7th 2025

HEOR scientists in the pharma industry must balance methodologic rigor with commercial expectations and timelines.

John Graham and Ross Maclean

Balancing the New Trend in HEOR Organizational Structure and Focus

ByJohn Graham, PharmD,Ross Maclean, MD
February 13th 2025

HEOR requires executive leaders who have both scientific and managerial acumen.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on PharmExec

    1

    Navigating Turbulent Markets: What Two Decades in Biotech Finance Taught Me About Building Companies That Last

    2

    FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus

    3

    Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion

    4

    How Do You Think Ai Can Improve FDA's Internal Process?

    5

    Pharmaceutical Executive Daily: FDA Approves Hepcludex

    • About
    • Advertise
    • Contact Us
    • Editorial Board
    • Editorial Submission Guidelines
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us